Shanghai Xuerong Biotechnology Co., Ltd. (SHE:300511)
China flag China · Delayed Price · Currency is CNY
5.39
-0.20 (-3.58%)
Sep 11, 2026, 4:00 PM EDT

SHE:300511 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
176.47161.45167.95252.67363.82340.77
Short-Term Investments
---0.06--
Trading Asset Securities
----270-
Cash & Short-Term Investments
176.47161.45167.95252.72633.82340.77
Cash Growth
130.95%-3.87%-33.54%-60.13%86.00%-55.16%
Accounts Receivable
43.7243.7731.3933.4829.0228.86
Other Receivables
5.258.65.556.2850.1318.89
Receivables
48.9752.3736.9539.7679.1547.74
Inventory
355.34371.68325.34442.86443.28384.08
Prepaid Expenses
3.933.982.95.743.972.11
Other Current Assets
21.9516.5613.1725.5132.34100.24
Total Current Assets
606.67606.04546.31766.61,193874.94
Property, Plant & Equipment
2,5812,6642,9653,4602,5792,945
Long-Term Investments
9.4812.0515.616.2421.4632.61
Other Intangible Assets
293.12299.43299.63306.9221.72328.38
Long-Term Deferred Tax Assets
-----12.83
Long-Term Deferred Charges
10.716.147.9121.8126.4847.77
Other Long-Term Assets
25.6614.0919.8730.6830.8295.96
Total Assets
3,5273,6013,8554,6024,0724,337

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Accounts Payable
267.86320.95298.35318.15215.87214.13
Accrued Expenses
60.5360.5278.0766.9261.8455.59
Short-Term Debt
939.1926.15985.851,036575.76777.49
Current Portion of Long-Term Debt
52.92114.07146.19168.69170.4248.23
Current Portion of Leases
4.051.151.054.011.131.07
Current Income Taxes Payable
0.020---0.01
Current Unearned Revenue
8.26.4720.627.1616.2314.15
Other Current Liabilities
300.16327.48418.11512.47256.29295.98
Total Current Liabilities
1,6331,7571,9482,1131,2981,607
Long-Term Debt
216.31219.98960.21948.27973.69954.69
Long-Term Leases
84.8828.9554.2924.4123.4523.45
Long-Term Unearned Revenue
54.2657.1960.5651.1243.8949.68
Other Long-Term Liabilities
5.8224.967.9433.08107.6451.12
Total Liabilities
1,9942,0883,0313,1702,4462,686

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Common Stock
640.85640.85498.82498.78503.04441.92
Additional Paid-In Capital
1,3211,314741.98741.82753.99471.77
Retained Earnings
-320.33-338.18-367.98249.09437.16724.38
Treasury Stock
-----16.43-34.7
Comprehensive Income & Other
-6.67-4.765.8164.8365.5165.98
Total Common Equity
1,6351,612938.631,5551,7431,669
Minority Interest
-102.68-98.53-115.31-122.15-117.43-17.5
Shareholders' Equity
1,5321,513823.321,4321,6261,652
Total Liabilities & Equity
3,5273,6013,8554,6024,0724,337

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Total Debt
1,2971,2902,1482,1811,7442,005
Net Cash (Debt)
-1,121-1,129-1,980-1,928-1,111-1,664
Net Cash Growth
------
Net Cash Per Share
-1.80-1.89-3.98-3.90-2.28-3.85
Filing Date Shares Outstanding
640.85640.85498.82498.78503.04507.6
Total Common Shares Outstanding
640.85640.85498.82498.78503.04441.92
Working Capital
-1,026-1,151-1,402-1,346-104.97-731.7
Book Value Per Share
2.552.521.883.123.473.78
Tangible Book Value
1,3421,313638.991,2481,5221,341
Tangible Book Value Per Share
2.092.051.282.503.023.03
Buildings
2,3232,3262,3162,2831,9291,922
Machinery
2,5762,5892,6872,5982,1872,209
Construction In Progress
70.3620.2853.49360.3168.28151.74